Olaparib trials for Pancreatic cancer

All Olaparib trials · All Pancreatic cancer trials

Phase breakdown

Recruiting trials studying Olaparib for Pancreatic cancer

• A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
  NCT05932862 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 32 locations
• APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
  NCT04858334 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 454 locations
• Pembrolizumab With Olaparib as Combined Therapy in Metastatic Pancreatic Cancer
  NCT05093231 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 17 locations
• Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
  NCT06545942 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 36 locations
• Targeted Pathway Inhibition in Patients With Pancreatic Cancer
  NCT04005690 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials study Olaparib for Pancreatic cancer?

5 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.